Spyre Therapeutics, Inc. · NASDAQ:SYRE
Fairmount Funds Management LLC sold 4,684,781 Spyre Therapeutics, Inc. shares (Form 4)
Traded Jun 23, 2026 · Filed Jun 23, 2026
On Jun 23, 2026, Fairmount Funds Management LLC (Director) sold 4,684,781 Spyre Therapeutics, Inc. shares at US$85.31 for US$400M, leaving 0 shares. Filed Jun 23, 2026 (Form 4).
- Sold
- 4,684,781 shares
- Price
- US$85.31
- Value
- US$400M
- Holding after
- 0 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 23, 2026 | Common Stock | Conversion | 666,680 | 4,684,781 | Indirect | |
| Jun 23, 2026 | Common Stock | Sale | 4,684,781 | US$85.31 | 0 | Indirect |
Source
Related
- Spyre Therapeutics, Inc.
- Fairmount Funds Management LLC
- Spyre Therapeutics, Inc. shareholders
- Schedule 13D/A · Harwin Peter Evan · Oct 9, 2026
- Form 4 · Burrows Scott L · Oct 2, 2026
- Form 4 · King-Jones Heidy · Oct 2, 2026
- Form 4 · Turtle Cameron · Oct 2, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Oct 1, 2026